The overactive bladder treatment market includes various
therapies, namely, anticholinergics, mirabegron, BOTOX, and neurostimulation
used to treat the sudden, involuntary contraction of the muscle in the urinary
bladder wall leading to urinary urgency, frequency, nocturia, and
urge-incontinence. The global market is projected to be valued at USD 3.63
Billion in 2017 and is expected to grow at a CAGR of 2.9% during the forecast
period to reach to USD 4.19 Billion by 2022. Base year considered for the report
is 2016. The development of innovative intravesical therapies, aggressive
marketing by pharma companies, and favorable demographics are the key factors
driving the growth of the market.
Objectives of the
Study
- · To define, describe, and forecast the global Overactive Bladder Treatment market on the basis of pharmacotherapy, disease type, and region
- · To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, trends, opportunities, and challenges)
- · To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the global market
- · To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
Browse and in-depth
TOC on "Overactive Bladder Treatment Market"
53 - Tables
39 - Figures
236 - Pages
Get Free 10%
customization:
Research Methodology
Top-down and bottom-up approaches were used to validate the
size of the global Overactive Bladder Treatment market and estimate the size of
other dependent submarkets. Various secondary sources such as associations,
including American Urology Association, National Center for Biotechnology
Information, U.S. National Library of Medicine, European Association of
Urology, Urology Care Foundation, National Association For Continence, National
Institutes of Health (NIH), Pharmaceutical Research and Manufacturers of
America, Centers for Disease Control and Prevention (CDC), U.S. Food and Drug
Administration (FDA), European Medicines Agency (EMA), directories, industry
journals, databases, and annual reports of the companies have been used to
identify and collect information useful for the study of market.
Target Audience:
- · Drug manufacturers, vendors, and distributors
- · Academic and government research institutes
- · Contract manufacturing organizations (CMOs) and contract research organizations (CROs)
- · Venture capitalists and investors
Overactive Bladder
Treatment Market, by Disease Type
·
Idiopathic Bladder Overactivity
·
Neurogenic Bladder Overactivity
To speak to our
analyst for a discussion on the above findings, click
Speak to Analyst
No comments:
Post a Comment